NCT04730362View on ClinicalTrials.gov

Effect of Laryngeal Mask Airway on Image Quality n Pediatric Patients Undergoing Magnetic Resonant Imaging

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Airway Obstruction
Interventions
DEVICE

guedel airway

"Anesthesia will be conducted by induction with 1-2~• Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%. The goal is to maintain the patient spontaneous ventilation throughout the procedure. Monitoring of the patients is done by MRI compatible pulse oximetry for heart rate and oxygen saturation which is connected to MRI control room."

DEVICE

supraglottic airway

supraglottic airway

DRUG

propofol bolus and then anesthesia sevoflurane

Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%

Trial Locations (1)

Unknown

Nataional Cancer Instituite, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT04730362 - Effect of Laryngeal Mask Airway on Image Quality n Pediatric Patients Undergoing Magnetic Resonant Imaging | Biotech Hunter | Biotech Hunter